Computational and biological perspective of phytoconstituents and their synthetic derivatives in antidiabetic therapy

The global rise in diabetes has intensified the search for safer, multi-target therapeutic options. Plant-based phytoconstituents and their synthetic derivatives are drawing attention for their promising antidiabetic effects and lower toxicity profiles. To critically review the antidiabetic potential of key phytoconstituents and their synthetic analogues, integrating insights from computational, in vitro, and in vivo studies. A systematic review of literature was conducted, focusing on studies employing molecular docking, preclinical assays, and mechanistic evaluations of phytochemicals targeting diabetes-related pathways. Compounds like berberine, curcumin, quercetin, and Gymnemic acid demonstrated strong binding affinities to targets such as PPARγ, α-glucosidase, and DPP-IV. Computational findings were supported by experimental data showing glucose-lowering, insulin-sensitizing, and antioxidant effects. Synthetic derivatives further improved bioactivity and pharmacokinetic profiles. Phytoconstituents and their optimized analogues hold strong promise as multi-target agents in antidiabetic therapy. Their translational potential underscores the need for continued preclinical and clinical investigation.